Zacks Investment Research
16 Jul 2026, 16:51 UTC · 1h ago
Danaher Gears Up to Post Q2 Earnings: Is a Beat in the Offing?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
16 Jul 2026, 16:51 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Danaher Corporation acquired Masimo Corp. in June 2026 for $9.9 billion. — A multi-billion dollar acquisition significantly alters the company's asset base and growth trajectory.
+0.60Danaher is scheduled to release second-quarter 2026 results on July 21, with consensus revenue estimated at $6.09 billion (up 2.6% YoY). — Earnings dates and growth estimates serve as near-term catalysts for stock price volatility.
+0.30Danaher has surpassed the Zacks Consensus Estimate for the bottom line in each of the preceding four quarters by an average of 6.7%. — A consistent track record of earnings beats typically increases investor confidence and supports a premium valuation.
+0.20Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
Positive outlook based on expected revenue growth, a history of earnings beats, and strength in bioprocessing and clinical diagnostics.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
42m ago
